Zhao Cheng

Real World Solutions, IQVIA, Finland

Poster(s):

• (A-033) Utilization of erenumab and other prophylactic migraine treatments: a regulator-mandated population-based cohort study in four Nordic countries (EUPAS36014)
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (B-096) Utilization of migraine treatments in pregnancy: results of a regulator-mandated population-based study in four Nordic countries (EUPAS36014)
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET